Brief: Palisade Bio Announces Two Abstracts Selected For Poster Presentations At Leading Global Inflammatory Bowel Disease Conferences
16/01/2026 13:31
Jan 16 (Reuters) - Palisade Bio Inc PALI.O: PALISADE BIO ANNOUNCES TWO ABSTRACTS SELECTED FOR POSTER PRESENTATIONS AT LEADING GLOBAL INFLAMMATORY BOWEL DISEASE CONFERENCES Source text: ID:nGNX3q3Xpl Further company coverage: PALI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing